Search research articles
Contact Us
Filters
Showing results (181-190 of 242) with videos related to
Page
of 25
Sort By:
Surgery
|
August 1, 1974
Thrombosis in the superior mesenteric and portal veins: report of a case treated with thrombectomy
S E Bergentz, B Ericsson, U Hedner, et al.
Thrombosis Research
|
March 1, 1991
Pharmacokinetics of a low molecular weight heparin, logiparin, after intravenous and subcutaneous administration to healthy volunteers
P C Pedersen, P B Ostergaard, U Hedner, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery
|
July 11, 1998
Local application of recombinant active-site inhibited human clotting factor VIIa reduces thrombus weight and improves patency in a rabbit venous thrombosis model
J Holst, A T Kristensen, H I Kristensen, et al.
Vox Sanguinis
|
November 5, 1999
Use of recombinant, activated factor VII in the treatment of congenital factor VII deficiencies
G Mariani, M G Testa, T Di Paolantonio, et al.
Bone Marrow Transplantation
|
March 29, 2002
Acquired factor VII deficiency in hematopoietic stem cell transplant recipients
A A Toor, A Slungaard, U Hedner, et al.
Pediatric Research
|
September 1, 1974
Fibrin-stabilizing factor (factor XIII) in the fetus and the newborn infant
P Henriksson, U Hedner, I M Nilsson, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
January 16, 1999
The effect of recombinant factor VIIa (NovoSeven) in healthy volunteers receiving acenocoumarol to an International Normalized Ratio above 2.0
E Erhardtsen, P Nony, M Dechavanne, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
September 14, 2001
Rationale for the use of high dose rFVIIa in a high-titre inhibitor patient with haemophilia B during major orthopaedic procedures
H A Cooper, C P Jones, E Campion, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 1, 1989
Effect of recombinant factor VIIa on the hemostatic defect in dogs with hemophilia A, hemophilia B, and von Willebrand disease
K M Brinkhous, U Hedner, J B Garris, et al.
Scandinavian Journal of Clinical and Laboratory Investigation
|
October 1, 1987
On the unreliability of one-stage factor VIII:C clotting assays after infusion of factor VIII concentrates
M Blombäck, H Kjellman, J P Allain, et al.
Page
of 25
Search research articles
Search
Showing results (181-190 of 242) with videos related to
Sort By:
Page
of 25
Surgery
|
August 1, 1974
Thrombosis in the superior mesenteric and portal veins: report of a case treated with thrombectomy
S E Bergentz, B Ericsson, U Hedner, et al.
Thrombosis Research
|
March 1, 1991
Pharmacokinetics of a low molecular weight heparin, logiparin, after intravenous and subcutaneous administration to healthy volunteers
P C Pedersen, P B Ostergaard, U Hedner, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery
|
July 11, 1998
Local application of recombinant active-site inhibited human clotting factor VIIa reduces thrombus weight and improves patency in a rabbit venous thrombosis model
J Holst, A T Kristensen, H I Kristensen, et al.
Vox Sanguinis
|
November 5, 1999
Use of recombinant, activated factor VII in the treatment of congenital factor VII deficiencies
G Mariani, M G Testa, T Di Paolantonio, et al.
Bone Marrow Transplantation
|
March 29, 2002
Acquired factor VII deficiency in hematopoietic stem cell transplant recipients
A A Toor, A Slungaard, U Hedner, et al.
Pediatric Research
|
September 1, 1974
Fibrin-stabilizing factor (factor XIII) in the fetus and the newborn infant
P Henriksson, U Hedner, I M Nilsson, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
January 16, 1999
The effect of recombinant factor VIIa (NovoSeven) in healthy volunteers receiving acenocoumarol to an International Normalized Ratio above 2.0
E Erhardtsen, P Nony, M Dechavanne, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
September 14, 2001
Rationale for the use of high dose rFVIIa in a high-titre inhibitor patient with haemophilia B during major orthopaedic procedures
H A Cooper, C P Jones, E Campion, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 1, 1989
Effect of recombinant factor VIIa on the hemostatic defect in dogs with hemophilia A, hemophilia B, and von Willebrand disease
K M Brinkhous, U Hedner, J B Garris, et al.
Scandinavian Journal of Clinical and Laboratory Investigation
|
October 1, 1987
On the unreliability of one-stage factor VIII:C clotting assays after infusion of factor VIII concentrates
M Blombäck, H Kjellman, J P Allain, et al.
Page
of 25